Re “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study”. Heerfordt et al [Letter]
Richard Hubbard, Victoria Carter, William Henley, David Price Observational and Pragmatic Research Institute, Cambridge, UKCorrespondence: David Price, Observational and Pragmatic Research Institute, 5 Coles Lane, Cambridge, CB24 3BA, UK, Email [email protected]
Saved in:
Main Authors: | Hubbard R, Carter V, Henley W, Price D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-02-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/re-ldquoinhaled-corticosteroid-particle-size-and-risk-of-hospitalizati-peer-reviewed-fulltext-article-COPD |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of patient compliance with inhaler therapy on chronic obstructive pulmonary disease severity: a rural tertiary care perspective
by: Nandakishore K. S., et al.
Published: (2025-02-01) -
Prevalence of Myocardial Infarction With Obstructive and Non-Obstructive Coronary Arteries in a Middle-Aged Population With Chronic Airflow Limitation: A Cross-Sectional Study
by: Sundh J, et al.
Published: (2025-02-01) -
Erythrocyte levels in chronic obstructive pulmonary disease (COPD) patients with a history of positive and negative COVID-19
by: Siti Nur Chasanah, et al.
Published: (2025-02-01) -
Ecofriendly colorimetric set-up coupled with mathematical filtration strategy for simultaneous determination of ipratropium and fenoterol in their novel anti-asthmatic metered dose inhaler
by: Salma N. Ali, et al.
Published: (2025-02-01) -
The impaired response of nasal epithelial cells to microplastic stimulation in asthma and COPD
by: Magdalena Paplińska-Goryca, et al.
Published: (2025-02-01)